These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4171834)

  • 21. Effect of ethyloestrenol on fibrinolysis in the vessel wall.
    Hedner U; Nilsson IM; Isacson S
    Br Med J; 1976 Sep; 2(6038):729-31. PubMed ID: 974570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenformin and ethyloestrenol for Raynaud's disease.
    Fearnley GR; Chakrabarti R
    Lancet; 1969 Oct; 2(7626):906-7. PubMed ID: 4186475
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological fibrinolysis.
    Fearnley GR
    Bristol Med Chir J; 1969 Oct; 84(312):131-43. PubMed ID: 5824915
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombogenesis in atherosclerosis of the coronary arteries].
    Petrova TP; Pavlishchuk SA
    Ter Arkh; 1968 Jan; 40(1):41-5. PubMed ID: 5747054
    [No Abstract]   [Full Text] [Related]  

  • 25. Coagulation abnormalities in subarachnoid hemorrhage.
    Ettinger MG
    Stroke; 1970; 1(3):139-42. PubMed ID: 5522910
    [No Abstract]   [Full Text] [Related]  

  • 26. Myocardial damage vis-a-vis plasma fibrinolytic activity and fibrinogen level--an experimental study.
    Saxena KK; Srivastava RK; Prasad DN
    Indian J Med Res; 1979 Aug; 70():263-7. PubMed ID: 521096
    [No Abstract]   [Full Text] [Related]  

  • 27. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1969 May; 1(7601):910-4. PubMed ID: 4180895
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinolysis and its pharmacological enhancement in occlusive vascular disease.
    Fearnley GR
    Adv Cardiol; 1970; 4():211-24. PubMed ID: 4924083
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1968 Nov; 2(7576):1004-7. PubMed ID: 4176859
    [No Abstract]   [Full Text] [Related]  

  • 32. Rheological and clotting changes in the immediate post-myocardial infarction period.
    Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behçet's disease with decreased fibrinolysis and superior vena caval occlusion.
    Chajek T; Fainaru M
    Br Med J; 1973 Mar; 1(5856):782-3. PubMed ID: 4694434
    [No Abstract]   [Full Text] [Related]  

  • 34. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
    Olszewski W; Laskowski S; Jeziorny J; Kogucki S
    Pol Tyg Lek; 1968 Dec; 23(49):1885-7. PubMed ID: 5704215
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nonenzymatic fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Liapina LA
    Kardiologiia; 1974 Nov; 14(11):14-8. PubMed ID: 4279308
    [No Abstract]   [Full Text] [Related]  

  • 37. Further experimental studies on the production of pulmonary infarction, especially from coagulative and fibrinolytic studies.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1971 May; 12(3):251-62. PubMed ID: 4255115
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival.
    Hickman JA
    J Clin Pathol; 1970 Dec; 23(9):797-800. PubMed ID: 5504373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery.
    Atkins P; Brown IK; Downie RJ; Haggart BG; Littler J; Robb PM; Santer GJ; Jones I
    Thromb Haemost; 1978 Feb; 39(1):89-96. PubMed ID: 580509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.